D-1362-2022 Class II Terminated
FDA drug recall D-1362-2022 was initiated by Amneal Pharmaceuticals Of New York, LLC on Jul 27, 2022 and is designated Class II. Reason for recall: Failed dissolution specifications. The recall status is terminated (terminated Aug 17, 2023). Affected quantity: 4,309 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 31, 2022
- Initiation Date
- Jul 27, 2022
- Termination Date
- Aug 17, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,309 bottles
Product description
Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10
Reason for recall
Failed dissolution specifications.
Distribution pattern
USA nationwide
Code information
Lot #: AR210705, Exp 04/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1362-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026